Skip to main content
Figure 4 | Arthritis Research & Therapy

Figure 4

From: Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trials

Figure 4

Relationships between CK and SCr and CRP using Phase 3 data. (A) CK increases at Week 12 by baseline CRP; baseline CRP Q1 < < Q4. (B) CK increases at Month 3 by change in CRP at Month 3; reductions in CRP Q1 > > Q4. (C) SCr increases at Month 3 by change in CK at Month 3; reductions in CK Q1 > > Q4.

Back to article page